Join us for the next webinar of the Road to Commercialization Symposium Series!
The topic: License to an Existing Company or Launch a Startup?
Learn how Innovation Ventures works with innovators to decide between launching a startup and licensing to an existing company, why a startup may be the right choice for a technology or an invention, what does it mean if you are interested in being a founder of a startup and the available resources at Innovation Ventures to help along the way.
MARIA GENNARO, MD, MSC
Professor of Medicine, Rutgers New Jersey Medical School
Professor of Epidemiology, Rutgers School of Public Health
Maria Gennaro is is a Professor of Medicine at Rutgers New Jersey Medical School and a Professor of Epidemiology at the Rutgers School of Public Health. She earned an M.D. In Italy, University of Palermo, and subsequently an M. Sc. at the London School of Hygiene and Tropical Medicine. The focus of Maria's work has always been infectious diseases, including TB and COVID-19. Her group has pursued both fundamental and translational studies on the stress responses of host and pathogen in tuberculosis, on new methods and platforms for TB diagnostics, and on antibody responses to SARS-CoV-2 infection. She will share the successful commercialization journey for the TB invention and licensing to Oxford Immunotech.
F. JAVIER DIEZ, PHD, MS
Professor of Mechanical & Aerospace Engineering, Rutgers School of Engineering
CEO, SubUAS LLC
F. Javier Diez is a Full Professor at Rutgers in the Dept. of Mechanical & Aerospace Engineering with a graduate faculty appointment in the Department of Electrical and Computer Engineering. He received his BS and MS from Saint Louis University and his PhD in Aerospace Engineering from the University of Michigan. His expertise includes UAV/UUV, aerodynamics and propulsion, aviation, and sensors, and he is the co-founder of two Rutgers startups, SubUAS, LLC and XTT, LLC. He is the CEO and president of SubUAS, LLC, a company that is commercializing the Naviator, the first unmanned vehicle that can fly, float, swim, dive, and transition between air and water in less than a second. He is the CTO of XTT, LLC, which is commercializing aerodynamic flow deflectors for enhancing wind turbine performance.
FOLLOWING THE KEYNOTE TALKS, THERE WILL BE A PANEL DISCUSSION ON STUDENT-LED RUTGERS STARTUP VISIKOL AND ITS ACQUISITION BY CELLINK (now BICO). THE WEBINAR WILL CONCLUDE WITH SHORT SESSIONS FOCUSING ON RESOURCES AT INNOVATION VENTURES, INCLUDING NEW VENTURES, I-CORPS, AND COMMERCIALIZATION FUNDING.
Tatiana Litvin-Vechnyak, PhD: Associate Vice President, Innovation Ventures, Rutgers Office for Research
Michael Johnson, PhD, Co-Founder, Visikol, Inc.
Deborah Perez, PhD, MBA, CLP: Associate Director of Licensing, Rutgers Innovation Ventures
Dan Benderly, MBA: Associate Director of New Ventures, Rutgers Innovation Ventures
1:00 p.m. - 2:00 p.m.
2:00 p.m. - 3:00 p.m.
3:00 p.m. - 4:00 p.m.
Resources at Innovation Ventures